A new therapeutic paradigm: radioiodine combined with lenvatinib for radioiodine-avid metastatic well-differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2025 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001980
Abstract: Purpose Metastatic well-differentiated thyroid cancer (WDTC) has significant morbidity and mortality. Multidisciplinary treatment, including high-dose radioiodine therapy (HDRI), has seldom complete response. Concerns are side effects, radioiodine refractoriness, and systemic metastasis. This study investigates the… read more here.
Keywords: hdri; avid metastatic; radioiodine; metastatic well ... See more keywords
PSMA-PET/CT-avid metastatic prostate cancer to the penis
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-233522
Abstract: Penile metastases from prostate cancer (PC) are rarely reported in the literature. Most commonly diagnosed due to presentation with malignant priapism and other urinary symptoms or from findings on clinical examination, prognosis has been reported… read more here.
Keywords: avid metastatic; pet avid; prostate cancer; psma pet ... See more keywords